Research points to the involvement of the EGFR/JNK/ERK signaling pathway in regulating chemoresistance mechanisms in gastric cancer; however, reports on its role in liver cancer resistance studies are limited [40]. This evidence concerns the gene MAPK8 and gastric cancer.